GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Iconovo AB (OSTO:ICO) » Definitions » Return-on-Tangible-Asset

Iconovo AB (OSTO:ICO) Return-on-Tangible-Asset : -120.20% (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Iconovo AB Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Iconovo AB's annualized Net Income for the quarter that ended in Mar. 2025 was kr-44.66 Mil. Iconovo AB's average total tangible assets for the quarter that ended in Mar. 2025 was kr37.15 Mil. Therefore, Iconovo AB's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 was -120.20%.

The historical rank and industry rank for Iconovo AB's Return-on-Tangible-Asset or its related term are showing as below:

OSTO:ICO' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -96.98   Med: -19.47   Max: 18.29
Current: -96.98

During the past 9 years, Iconovo AB's highest Return-on-Tangible-Asset was 18.29%. The lowest was -96.98%. And the median was -19.47%.

OSTO:ICO's Return-on-Tangible-Asset is ranked worse than
87.64% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: -0.995 vs OSTO:ICO: -96.98

Iconovo AB Return-on-Tangible-Asset Historical Data

The historical data trend for Iconovo AB's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iconovo AB Return-on-Tangible-Asset Chart

Iconovo AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only -19.47 -28.36 -60.59 -95.48 -93.58

Iconovo AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -70.32 -67.10 -110.51 -113.66 -120.20

Competitive Comparison of Iconovo AB's Return-on-Tangible-Asset

For the Medical Devices subindustry, Iconovo AB's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Iconovo AB's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Iconovo AB's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Iconovo AB's Return-on-Tangible-Asset falls into.


;
;

Iconovo AB Return-on-Tangible-Asset Calculation

Iconovo AB's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-41.14/( (43.21+44.711)/ 2 )
=-41.14/43.9605
=-93.58 %

Iconovo AB's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=-44.66/( (44.711+29.597)/ 2 )
=-44.66/37.154
=-120.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2025) net income data.


Iconovo AB  (OSTO:ICO) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Iconovo AB Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Iconovo AB's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Iconovo AB Business Description

Traded in Other Exchanges
N/A
Address
Ideongatan 3 A-B, Delta 6, Lund, SWE, SE-223 62
Iconovo AB develops new inhaled medicinal products in collaboration with international pharmaceutical companies. The company provides several types of patent-protected inhalers that can generate significant commercial opportunities in the development of novel pharmaceuticals and vaccines and at patent expirations for established pharmaceuticals. The project is a generic version of the asthma and COPD product Symbicort.

Iconovo AB Headlines

No Headlines